Snapshots of the flu virus replication machine in action
By Mathias Jäger
EMBL scientists investigate how influenza virus responds to new drug treatment
By Iris Kruijen
ERC grantee Stephen Cusack shares his vision for the next ten years
By Edward Dadswell
Understanding how the flu virus steals host RNA offers hope of new drugs
By Rosemary Wilson
A new crystallography platform in Grenoble opens the door to new technological developments
By Isabelle Kling
EMBL researchers help to design a lead compound active against four different pathogens
By Margaux Phares
Stephen Cusack looks back on the early days of his collaboration with Anacor developing anti-infectives
By Guest author(s)
Andrés Palencia on the design of compounds that may help fight drug-resistant TB and more
Studying at EMBL in Grenoble helps Japanese postdoc see her native country through different eyes
Andrew Miller, first head of EMBL Grenoble, reflects on four decades at the Outstation.
By Adam Gristwood
Looking for past print editions of EMBLetc.?
Browse our archive, going back 20 years.